Patents by Inventor Jong-Jye Lin

Jong-Jye Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060148714
    Abstract: The present invention relates generally to small peptide-based constructs, including derivatized constructs, and their therapeutic uses. The sequences of these constructs are based on a reverse subsequence derived from Domain II of bactericidal/permeability-increasing protein (BPI).
    Type: Application
    Filed: October 27, 2005
    Publication date: July 6, 2006
    Inventors: Roger Little, Jong-Jye Lin, J.G.Kinyua Gikonyo
  • Patent number: 6964948
    Abstract: The present invention relates generally to small peptide-based constructs, including derivatized constructs, and their therapeutic uses. The constructs and derivatized constructs can have at least one of heparin binding, heparin neutralizing, endothelial cell proliferation inhibiting, antiangiogenic, LPS binding, LPS neutralization, or antimicrobial properties. The sequences of these constructs are based on a reverse subsequence derived from Domain II of bactericidal/permeability-increasing protein (BPI).
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: November 15, 2005
    Assignee: Xoma Technology Ltd.
    Inventors: Roger G. Little, II, Jong-Jye Lin, J. G. Kinyua Gikonyo
  • Patent number: 6906037
    Abstract: The present invention relates generally to small peptide-based constructs and their therapeutic uses. The sequences of these peptide-based constructs are based on a reverse subsequence derived from Domain II of bactericidal/permeability-increasing protein (BPI).
    Type: Grant
    Filed: February 4, 2003
    Date of Patent: June 14, 2005
    Assignee: Xoma Technology Ltd.
    Inventors: Roger G. Little, II, Jong-Jye Lin
  • Publication number: 20040048793
    Abstract: The present invention relates generally to small peptide-based constructs and their therapeutic uses. The sequences of these peptide-based constructs are based on a reverse subsequence derived from Domain II of bactericidal/permeability-increasing protein (BPI).
    Type: Application
    Filed: February 4, 2003
    Publication date: March 11, 2004
    Inventors: Roger G. Little, Jong-Jye Lin
  • Publication number: 20030166528
    Abstract: The present invention relates generally to a novel peptide, XMP.676, derived from or based on Domain III (amino acids 142-169) of bactericidal/permeability-increasing protein (BPI) and therapeutic uses of this peptide.
    Type: Application
    Filed: October 11, 2001
    Publication date: September 4, 2003
    Inventor: Jong-Jye Lin
  • Publication number: 20030144195
    Abstract: The present invention relates generally to small peptide-based constructs, including derivatized constructs, and their therapeutic uses. The sequences of these constructs are based on a reverse subsequence derived from Domain II of bactericidal/permeability-increasingprotein (BPI).
    Type: Application
    Filed: July 30, 2002
    Publication date: July 31, 2003
    Inventors: Roger G. Little, Jong-Jye Lin, J.G. Kinyua Gikonyo
  • Patent number: 6515104
    Abstract: The present invention relates generally to small peptide-based constructs and their therapeutic uses. The sequences of these peptide-based constructs are based on a reverse subsequence derived from Domain II of bactericidal/permeability-increasing protein (BPI).
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: February 4, 2003
    Assignee: Xoma Technology Ltd.
    Inventors: Roger G. Little, II, Jong-Jye Lin
  • Patent number: 6423825
    Abstract: The present invention relates generally to small derivatized peptide-based constructs and their therapeutic uses. The sequences of these derivatized peptide-based constructs are based on a reverse subsequence derived from Domain II of bactericidal/permeability-increasing protein (BPI).
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: July 23, 2002
    Assignee: Xoma Technology Ltd.
    Inventors: Roger G. Little, II, Jong-Jye Lin, J. G. Kinyua Gikonyo
  • Patent number: 6355616
    Abstract: The present invention relates generally to derivatized antifungal compounds that are peptide-based constructs derived from or based on subsequences of Domain III (amino acids 142-169) of bactericidal/permeability-increasing protein (BPI) and in vivo or in vitro uses of such compounds.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: March 12, 2002
    Assignee: Xoma (US) Technology Ltd.
    Inventors: Roger G. Little, II, Jong-Jye Lin, J. G. Kinyua Gikonyo